Hotez, Peter J.
Article History
First Online: 1 August 2022
Competing interests
: P.J.H. is a co-inventor of a COVID-19 recombinant protein vaccine technology owned by Baylor College of Medicine (BCM) that was recently licensed by BCM non-exclusively and with no patent restrictions to several companies committed to advance vaccines for LMICs. The co-inventors have no involvement in license negotiations conducted by BCM. Similar to other research universities, a long-standing BCM policy provides its faculty and staff, who make discoveries that result in a commercial license, a share of any royalty income. So far, BCM has not distributed any royalty income to the co-inventors of the COVID-19 recombinant protein vaccine technology. P.J.H. is also the author of several books published by Johns Hopkins University Press and ASM-Wiley Press and receives royalties from those books.
Free to read: This content has been made available to all.